GEDI Exchange

Member profile: Cosm

Cosm device translucent ring

Cosm knows that every pelvis is different. A treatment can work for one person, while that same treatment may not work for another. Providing unique solutions for personalized care is Cosm’s focus on decreasing suffering from pelvic floor issues. Cosm discusses their personalized medical devices and how they view the GEDI Exchange as a resource to connect and collaborate for support on their product.

In a short pitch, how would you describe Cosm’s offerings (products and services)? What makes it innovative? What industry sectors and/or customers are you focused on?

Cosm is delivering personalized medical devices to women suffering from pelvic floor disorders resulting from surgery, prolapse, and many others. Through a seamless digital urogynecologic platform that combines proprietary diagnostics, AI, cloud software, and 3D printing, Cosm is commercializing the world’s first personalized pessary platform, Gynethotics. When it comes to prolapse diagnosis, we are disrupting the current clinical standards of subjective finger measurements with a novel proprietary ultrasound-based diagnostic technique to scan and mould a patient’s pelvic floor and vaginal cavity.

The use of advanced technologies such as machine learning and AI to analyze the ultrasound images and take measurements of physiology, function, and soft-tissue biomechanics, helps clinicians personalize pessaries for their patients. For treatment, we are disrupting the market of standard, mass produced pessaries of 100+ shapes and sizes fit by trial and error.  Instead, Cosm uses 3D printing to create pessaries unique to each woman’s body and needs. Clinicians and patients will have continuity of care by tracking outcomes through seamless digital health software.

Providing more detail, what is the value proposition of Cosm’s offerings? Examples could include the underlying technology, new capabilities, cost reduction, risk reduction, improved performance, new business model, etc.

Cosm is taking a novel, data-driven approach to quantify the pelvic floor and create Gynethotics - a product designed to provide effective custom conservative therapy with an improved fit, support, and ease of use. Gynethotics allows providers to offer a better quality of care by eliminating guesswork and error-prone manual measurement techniques, reducing inventory costs, increasing profitability, and improving workflow and continuity of care. Cosm’s technology revamps the clinician and patient experience. The technology allows more women to live and age with dignity and grace by enhancing fitting success (current ~30% failure rate with pessaries), patient compliance (currently 50% discontinue the use of their pessary within two years) and lowering complication rates (currently 56% experience significant issues with long-term use).                  

What is Cosm’s biggest achievement/success story to date?

We have successfully passed all biocompatibility, bench testing, quality assurance tests, and received Health Canada Investigational Testing Authorization (ITA) approval to run a clinical study and put the first Gynethotic in a woman in the upcoming months.  We have also completed Health Canada and FDA ‘pre-sub’ meetings, validating a clear path to market for our products. We have received confirmation of Canadian private health insurance coverage for 13 million women at a premium price point, allowing us to pursue a similar business model to custom orthotics, dental devices, and hearing aids within gynecology.

What does the future hold for Cosm?

We are currently preparing for our seed round raise to provide the capital necessary to push for Health Canada and U.S. Food and Drug (FDA) approval for Gynethotics by 2023 to begin serving patients and clinicians by modernizing pessary care. Our ultimate goal is to provide life-changing, hassle-free, patient-specific devices while dismantling the stigma surrounding pelvic floor disorders.

What is Cosm’s connection to the University of Waterloo?

Our chief technology officer, Aye Nyein San, received her BASc at the University of Waterloo in systems design engineering. Aye continues to be an active member of the UWaterloo community. We had the pleasure of taking on multiple Co-op students from UWaterloo to drive our technology forward and are currently exploring a research project with the Multi-Scale Additive Manufacturing Lab (MSAM).

Why did you decide to join the GEDI Exchange? What are you looking for? What do you want to get out of it?

We greatly value the impact of Communitech on our growth and are excited to go down a similar path by becoming a member of the GEDI Exchange. We are looking forward to connecting with community members while driving company growth and exploring UWaterloo’s research and offerings to support our product development.

Cosm lgo